Sana Biotechnology Inc

SANA

Company Profile

  • Business description

    Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

  • Contact

    188 East Blaine Street
    Suite 400
    SeattleWA98102
    USA

    T: +1 206 701-7914

    E: [email protected]

    https://www.sana.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    194

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,421.7021.900.26%
CAC 407,694.4467.600.89%
DAX 4023,352.69236.731.02%
Dow JONES (US)41,707.38593.411.44%
FTSE 1008,531.6127.72-0.32%
HKSE22,775.9284.040.37%
NASDAQ18,068.85330.691.86%
Nikkei 22536,928.63148.970.41%
NZX 50 Index12,467.0329.86-0.24%
S&P 5005,711.2579.971.42%
S&P/ASX 2008,191.7013.400.16%
SSE Composite Index3,352.009.330.28%

Market Movers